Press Releases

See what's up at Voluntis

Press Release 23 July 2021
Voluntis announces the execution of a Share Purchase Agreement between its reference shareholders and Aptar regarding the acquisition of a majority stake in Voluntis at a price of €8.70 per share
Learn more
Press Release 5 July 2021
Désignation d’un expert indépendant dans le cadre du projet d’acquisition de Voluntis par Aptar
Learn more
Press Release 2 July 2021
Bilan semestriel du contrat de liquidité contracté avec Gilbert Dupont
Learn more
Press Release 22 June 2021
Exclusive negotiations regarding a potential acquisition of Voluntis by Aptar to expand in digital therapeutics
Learn more
Press Release 9 June 2021
Voluntis, pionnier des thérapies numériques devenu un leader mondial, affiche ses ambitions de croissance rentable
Learn more
Press Release 7 June 2021
Voluntis receives FDA 510(k) clearance for a new version of Insulia supporting an expanded range of basal insulins
Learn more
Press Release 28 May 2021
Éligibilité des actions Voluntis au PEA-PME
Learn more
Press Release 12 May 2021
Voluntis receives CE Mark for new version of Oleena with expanded clinical intelligence
Learn more